Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials

  1. Matos, I.
  2. Noguerido, A.
  3. Ros, J.
  4. Mulet, N.
  5. Argilés, G.
  6. Elez, É.
  7. Tabernero, J.
Aldizkaria:
Expert Opinion on Investigational Drugs

ISSN: 1744-7658,  1354-3784

Argitalpen urtea: 2019

Alea: 28

Zenbakia: 5

Orrialdeak: 463-471

Mota: Artikulua

DOI: 10.1080/13543784.2019.1599860 GOOGLE SCHOLAR
Datuen iturria: Scopus